| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
White paper |
a Past-Chairman, American Medical Informatics Association, Associate Clinical Professor of Medicine, Harvard Medical School/Beth Israel Deaconess Medical Center, Boston, MA
b Associate Vice President, American Medical Informatics Association, Bethesda, MD
c Professor, Fuqua School of Business, Duke University, Durham, NC
d Director, Healthcare Informatics, Pfizer, Inc. NY, NY
e Director, Data Exploration Sciences, GlaxoSmithKline, King of Prussia, PA
f Chairman of the Board, American Medical Informatics Association, Bethesda, MD, Chief Medical Information Officer, Palo Alto Medical Foundation, Palo Alto, CA
g President and CEO, American Medical Informatics Association, Bethesda, MD, Professor of Medical Education, University of Virginia, Charlottesville, VA.
* Correspondence and reprints: Meryl Bloomrosen, MBA, American Medical Informatics Association, 4915 St. Elmo Avenue, Suite 401, Bethesda, MD 20814; Tel: (301) 657-1291 (Email: meryl{at}amia.org).
Received for publication: 09/11/06; accepted for publication: 10/09/06.
Secondary use of health data applies personal health information (PHI) for uses outside of direct health care delivery. It includes such activities as analysis, research, quality and safety measurement, public health, payment, provider certification or accreditation, marketing, and other business applications, including strictly commercial activities. Secondary use of health data can enhance health care experiences for individuals, expand knowledge about disease and appropriate treatments, strengthen understanding about effectiveness and efficiency of health care systems, support public health and security goals, and aid businesses in meeting customers needs. Yet, complex ethical, political, technical, and social issues surround the secondary use of health data. While not new, these issues play increasingly critical and complex roles given current public and private sector activities not only expanding health data volume, but also improving access to data. Lack of coherent policies and standard "good practices" for secondary use of health data impedes efforts to strengthen the U.S. health care system. The nation requires a framework for the secondary use of health data with a robust infrastructure of policies, standards, and best practices. Such a framework can guide and facilitate widespread collection, storage, aggregation, linkage, and transmission of health data. The framework will provide appropriate protections for legitimate secondary use.
This article has been cited by other articles:
![]() |
B. Tulu and T. A. Horan The Electronic Disability Record: Purpose, Parameters, and Model Use Case J. Am. Med. Inform. Assoc., January 1, 2009; 16(1): 7 - 13. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Kim, C. U. Lehmann, and and the Council on Clinical Information Technology Pediatric Aspects of Inpatient Health Information Technology Systems Pediatrics, December 1, 2008; 122(6): e1287 - e1296. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bloomrosen and D. Detmer Advancing the Framework: Use of Health Data--A Report of a Working Conference of the American Medical Informatics Association J. Am. Med. Inform. Assoc., November 1, 2008; 15(6): 715 - 722. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kim, S. Labkoff, and S. H. Holliday Opportunities for Electronic Health Record Data to Support Business Functions in the Pharmaceutical Industry--A Case Study from Pfizer, Inc. J. Am. Med. Inform. Assoc., September 1, 2008; 15(5): 581 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Bouhaddou, P. Warnekar, F. Parrish, N. Do, J. Mandel, J. Kilbourne, and M. J. Lincoln Exchange of Computable Patient Data between the Department of Veterans Affairs (VA) and the Department of Defense (DoD): Terminology Mediation Strategy J. Am. Med. Inform. Assoc., March 1, 2008; 15(2): 174 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Post and J. H. Harrison Jr. PROTEMPA: A Method for Specifying and Identifying Temporal Sequences in Retrospective Data for Patient Selection J. Am. Med. Inform. Assoc., September 1, 2007; 14(5): 674 - 683. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |